We have assigned a new Management&Governance (M&G) assessment of neutral to pharmaceutical company, AbbVie Inc. The M&G assessment follows the Jan. 7 publication of S&P Global Ratings' revised criteria for evaluating the credit risks presented by an entity's M&G framework. (See Management And Governance Credit Factors For Corporate Entities published Jan. 7, 2023). Following the new M&G assessment, all our ratings on AbbVie Inc. remain unchanged. S&P Global Ratings today assigned a new M&G modifier assessment of neutral to AbbVie Inc. The action follows the revision to our criteria for evaluating the credit risks presented by an entity's management and governance framework. The terms management and governance encompass the broad range of oversight and direction conducted by an
